These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 121655)

  • 21. Dermal preservation using the Versajet hydrosurgery system for debridement of paediatric burns.
    Cubison TC; Pape SA; Jeffery SL
    Burns; 2006 Sep; 32(6):714-20. PubMed ID: 16849034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical burn wound therapy.
    Artz CP; Yarbrough DR
    Surg Annu; 1974; 6():349-62. PubMed ID: 4215165
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of Travase on heat-injured skin.
    Zawacki BE
    Surgery; 1975 Jan; 77(1):132-6. PubMed ID: 1109512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary study on the improvement of wound microcirculation and retrospection on several methods of the management of deep partial thickness burn wound].
    Sun YH; Yu DN; Chen X; Hu XH; Zhang GA; Yan RY; Tan FJ
    Zhonghua Shao Shang Za Zhi; 2005 Feb; 21(1):17-20. PubMed ID: 15796836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [REVIEW OF 30 YEARS OF RESEARCH AND DEVELOPMENT OF AN ENZYMATIC DEBRIDEMENT AGENT FOR BURNS].
    Krieger Y; Shoham Y; Bogdanov-Berezovsky A; Silberstein E; Sagi A; Levy A; Rosenberg N; Rubin G; Egozi D; Ullman Y; Haik J; Rosenberg L
    Harefuah; 2016 May; 155(5):281-5, 323, 322. PubMed ID: 27526555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The continuing problem of sepsis-following enzymatic debridement of burns.
    Hummel RP; Kautz PD; MacMillan BG; Altemeier WA
    J Trauma; 1974 Jul; 14(7):572-9. PubMed ID: 4210256
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of eschar grinding and biological dressing A for treatment of deep partial-thickness burn wound on the extremities].
    Zhou YP; Zhang CX; Chen GB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):680-2. PubMed ID: 16762884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further observations on the use of proteolytic enzymes in the removal of the burn eschar.
    CONNELL JF; ROUSSELOT LM
    Surg Forum; 1955; 5():774-9. PubMed ID: 13247132
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental enzymatic necrolysis and necrectomy in burns.
    Moserová J; Bĕhounková E; Konícková Z
    Acta Chir Plast; 1976; 18(3):135-42. PubMed ID: 65086
    [No Abstract]   [Full Text] [Related]  

  • 30. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C; Kreken Almeland S; Dheansa B; Fuchs P; Governa M; Hoeksema H; Korzeniowski T; Lumenta DB; Marinescu S; Martinez-Mendez JR; Plock JA; Sander F; Ziegler B; Kneser U
    Burns; 2020 Jun; 46(4):782-796. PubMed ID: 32241591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of vibriolysin, an enzymatic debriding agent, on healing of partial-thickness burn wounds.
    Nanney LB; Fortney DZ; Durham DR
    Wound Repair Regen; 1995; 3(4):442-8; discussion 540-1. PubMed ID: 17147655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel technique of NexoBrid™ application to burns on the hands.
    Rigueros Springford L; Creasy H; Cubison T; Dheansa B
    Burns; 2017 Aug; 43(5):1132-1133. PubMed ID: 28330824
    [No Abstract]   [Full Text] [Related]  

  • 33. Collagenase for enzymatic debridement: a systematic review.
    Ramundo J; Gray M
    J Wound Ostomy Continence Nurs; 2009; 36(6 Suppl):S4-11. PubMed ID: 19918148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-inflammatory action of Bacillus sublitis protease, with special reference to enzymatic activity and relation between anti-inflammatory action and substrate specificity].
    Kobayashi S; Yasui O; Masuzumi M
    Saishin Igaku; 1968 Oct; 23(10):2206-15. PubMed ID: 4975443
    [No Abstract]   [Full Text] [Related]  

  • 35. Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment.
    Foti C; Conserva A; Casulli C; Scrimieri V; Pepe ML; Quaranta D
    Contact Dermatitis; 2007 Jun; 56(6):361-2. PubMed ID: 17577383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial debridement of the burn eschar: the in vivo activity of selected organisms.
    Stone LL; Dalton HP; Haynes BW
    J Surg Res; 1980 Jul; 29(1):83-92. PubMed ID: 6775153
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of immobilized proteases in preparing burn wounds for plastic closure].
    Potapskiĭ IuP; Davidenko TI; Chuenko AV; Fomichev AA; Shatalov VF
    Klin Khir (1962); 1988; (3):46-8. PubMed ID: 3043080
    [No Abstract]   [Full Text] [Related]  

  • 38. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.
    Korzeniowski T; Strużyna J; Chrapusta AM; Krajewski A; Kucharzewski M; Piorun K; Nowakowski J; Surowiecka A; Kozicka M; Torres K
    Med Sci Monit; 2022 Jan; 28():e935632. PubMed ID: 35064095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary evaluation of vibriolysin, a novel proteolytic enzyme composition suitable for the debridement of burn wound eschar.
    Durham DR; Fortney DZ; Nanney LB
    J Burn Care Rehabil; 1993; 14(5):544-51. PubMed ID: 8245109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic degradation of polymyxins by the enzymes of Bacillus polymyxa.
    Woyczikowska B; Paśś L; Girdwoyń M; Raczyńska-Bojanowska K
    Acta Biochim Pol; 1973; 20(3):285-96. PubMed ID: 4356177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.